retatrutide triple agonist gip glp-1 glucagon phase 3 2025 🚨 Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and type 2 diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ The TRIUMPH-1 Phase 3 results

Key reminder: Lipotropic injections are a prescription therapy and should only be administered under medical supervision to ensure dosing, frequency, and safety monitoring are appropriate for your health needs

10.3389/fcvm.2024.1406856 182 ZakirovaZ.ReedJ.CrynenG.HorneL.HassanS.MathuraV.et al

For users priced out of the medical system, the temptation is irresistible

usually occurs alongside other deficiencies due to poor diet

She said especially a lot of women dont like to do that

Lipotropic injections are often used as part of a comprehensive weight loss plan and are especially beneficial for those who have hit a plateau in their weight loss journey